165 related articles for article (PubMed ID: 34292158)
1. Ophthalmic artery Doppler in the prediction of preeclampsia.
Nicolaides KH; Sarno M; Wright A
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1098-S1101. PubMed ID: 34292158
[TBL] [Abstract][Full Text] [Related]
2. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 35-37 weeks' gestation.
Sarno M; Wright A; Vieira N; Sapantzoglou I; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Apr; 57(4):600-606. PubMed ID: 33073902
[TBL] [Abstract][Full Text] [Related]
4. Maternal vascular indices at 36 weeks' gestation in the prediction of preeclampsia.
Mansukhani T; Wright A; Arechvo A; Lamanna B; Menezes M; Nicolaides KH; Charakida M
Am J Obstet Gynecol; 2024 Apr; 230(4):448.e1-448.e15. PubMed ID: 37778678
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic artery Doppler at 36 weeks' gestation in prediction of pre-eclampsia: validation and update of previous model.
Mansukhani T; Wright A; Arechvo A; Laich A; Iglesias M; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Feb; 63(2):230-236. PubMed ID: 37616530
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ophthalmic artery Doppler with PlGF and sFlt-1/PlGF ratio at 35-37 weeks' gestation in prediction of imminent pre-eclampsia.
Lau K; Wright A; Sarno M; Kametas NA; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 May; 59(5):606-612. PubMed ID: 35132725
[TBL] [Abstract][Full Text] [Related]
7. Ophthalmic artery Doppler in prediction of pre-eclampsia at 35-37 weeks' gestation.
Sarno M; Wright A; Vieira N; Sapantzoglou I; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Nov; 56(5):717-724. PubMed ID: 32857890
[TBL] [Abstract][Full Text] [Related]
8. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
[TBL] [Abstract][Full Text] [Related]
9. Ophthalmic artery Doppler at 11-13 weeks' gestation in prediction of pre-eclampsia.
Gana N; Sarno M; Vieira N; Wright A; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Jun; 59(6):731-736. PubMed ID: 35642909
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
Chaemsaithong P; Gil MM; Chaiyasit N; Cuenca-Gomez D; Plasencia W; Rolle V; Poon LC
Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic artery Doppler at 19-23 weeks' gestation in pregnancies that deliver small-for-gestational-age neonates.
Abdel Azim S; Wright A; Sapantzoglou I; Nicolaides KH; Charakida M
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):52-58. PubMed ID: 35441758
[TBL] [Abstract][Full Text] [Related]
12. Prediction of imminent preeclampsia at 35-37 weeks gestation.
Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
[TBL] [Abstract][Full Text] [Related]
13. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
[TBL] [Abstract][Full Text] [Related]
14. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
[TBL] [Abstract][Full Text] [Related]
15. Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation.
Wright A; Wright D; Syngelaki A; Georgantis A; Nicolaides KH
Am J Obstet Gynecol; 2019 Feb; 220(2):197.e1-197.e11. PubMed ID: 30414394
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic artery Doppler at 35-37 weeks' gestation in pregnancies with small or growth-restricted fetuses.
Abdel Azim S; Sarno M; Wright A; Vieira N; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Apr; 59(4):483-489. PubMed ID: 35000242
[TBL] [Abstract][Full Text] [Related]
17. Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study.
Anzoategui S; Gibbone E; Wright A; Nicolaides KH; Charakida M
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):207-214. PubMed ID: 35502146
[TBL] [Abstract][Full Text] [Related]
18. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
[TBL] [Abstract][Full Text] [Related]
19. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation.
Döbert M; Wright A; Varouxaki AN; Mu AC; Syngelaki A; Rehal A; Delgado JL; Akolekar R; Muscettola G; Janga D; Singh M; Martin-Alonso R; Dütemeyer V; De Alvarado M; Atanasova V; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):69-75. PubMed ID: 34580947
[TBL] [Abstract][Full Text] [Related]
20. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation.
Wright D; Dragan I; Syngelaki A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Feb; 49(2):194-200. PubMed ID: 27671544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
